Commonwealth Equity Services, LLC
- SEC CIK
- 0000312272
- Latest filing
- Jul 29, 2026
RXRX holding history
Recursion Pharmaceuticals, Inc. in every 13F filed by Commonwealth Equity Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RXRX overviewAll 13F holders of RXRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 291,939
- Value
- $1.07M
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 291,939 | $1.07M | <0.1% | −29,052−9.1% | Reduced | Holders |
| Q1 2026 | 320,991 | $985.4K | <0.1% | +235,648+276.1% | Added | Holders |
| Q4 2025 | 85,343 | $349.1K | <0.1% | +39,303+85.4% | Added | Holders |
| Q3 2025 | 46,040 | $225.0K | <0.1% | −13,581−22.8% | Reduced | Holders |
| Q2 2025 | 59,621 | $302.0K | <0.1% | −6,722−10.1% | Reduced | Holders |
| Q1 2025 | 66,343 | $351.0K | <0.1% | +12,024+22.1% | Added | Holders |
| Q4 2024 | 54,319 | $367.0K | <0.1% | −4,582−7.8% | Reduced | Holders |
| Q3 2024 | 58,901 | $388.0K | <0.1% | +14,660+33.1% | Added | Holders |
| Q2 2024 | 44,241 | $332.0K | <0.1% | +9,058+25.7% | Added | Holders |
| Q1 2024 | 35,183 | $351.0K | <0.1% | +13,183+59.9% | Added | Holders |
| Q4 2023 | 22,000 | $217.0K | <0.1% | +815+3.8% | Added | Holders |
| Q3 2023 | 21,185 | $162.0K | <0.1% | +5,550+35.5% | Added | Holders |
| Q2 2023 | 15,635 | $117.0K | <0.1% | +15,635 | New | Holders |